-
181
Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
Published 2011-01-01“…No significant differences were observed between neuroblastoma with and without NMYC oncogene amplification, suggesting that expression of NeuGc-GM3 is preserved in more aggressive cancers. Until now, the expression of N-glycolylated gangliosides in pediatric neuroectodermal tumors has not been investigated. …”
Get full text
Article -
182
Comparison of the Effectiveness of Parent-Centered Meta-Emotional Training and Family-Centered Play Therapy in Reducing Aggression in Preschool Children
Published 2024-12-01Subjects: “…aggression…”
Get full text
Article -
183
‘If one doesn't happen, the other will’: forensic mental health service patients’ experiences of co-occurring self-harm and aggression
Published 2025-01-01Subjects: Get full text
Article -
184
Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study
Published 2020-09-01“…This paper describes the protocol for a study: (1) to assess the feasibility of collecting longitudinal data on cognition via self-report, neuropsychological testing, peripheral markers of inflammation and neuroimaging and (2) to explore and describe patterns of cancer-related cognitive impairment over the course of treatment and recovery in patients with newly diagnosed, aggressive lymphoma undergoing standard therapy with curative intent.Methods and analysis This is a prospective, longitudinal, feasibility study in which 30 newly diagnosed, treatment-naive patients with aggressive lymphoma will be recruited over a 12-month period. …”
Get full text
Article -
185
-
186
Perspectives of physicians on risk factors for patient aggression and violence against physicians in Chinese hospitals: a Q-methodology study
Published 2025-01-01Subjects: Get full text
Article -
187
-
188
Tumor aggression-defense index–a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer
Published 2025-01-01Subjects: Get full text
Article -
189
Long Complete Remission Achieved with the Combination Therapy of Cisplatin and Gemcitabine in a Patient with Aggressive Natural Killer Cell Leukemia
Published 2015-01-01“…Aggressive natural killer cell leukemia (ANKL) is a rare and often lethal lymphoproliferative disorder. …”
Get full text
Article -
190
-
191
Cytoplasmic SALL4-A isoform expression as a diagnostic marker of less aggressive tumor behavior in gastric cancer
Published 2025-02-01“…Conclusion Cytoplasmic SALL4-A expression in GC is associated with less aggressive tumor phenotypes and shows promise as a diagnostic marker. …”
Get full text
Article -
192
-
193
Effects of neonatal handling on behavior and stress-response in rats selected for reaction towards humans
Published 2016-05-01Subjects: Get full text
Article -
194
Early life stress and altered social behaviors: A perspective across species
Published 2025-02-01Subjects: Get full text
Article -
195
Psychological Characteristics of the Emotional Sphere of Internally Displaced Persons from the First and Second Waves
Published 2024-06-01Subjects: Get full text
Article -
196
Towards recognition of peer violence in youth sports – the case of Vojvodina
Published 2020-12-01Subjects: Get full text
Article -
197
Workplace Bullying among Business Professionals: Prevalence, Gender Differences and the Role of Organizational Politics
Published 2005-11-01Subjects: Get full text
Article -
198
Aggression and its correlation with plasma C-reactive protein levels in patients with schizophrenia: A hospital based cross-sectional study
Published 2023-06-01“…Aims: To assess aggression and plasma CRP in patients with schizophrenia and to compare aggression in patients with normal and elevated CRP. …”
Get full text
Article -
199
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Published 2025-01-01“…BackgroundSelect patients with relapsed/refractory aggressive B cell lymphoma may benefit from bridging radiation (bRT) prior to anti-CD19-directed chimeric antigen receptor T cell therapy (CAR-T). …”
Get full text
Article -
200